|Bid||9.78 x 1400|
|Ask||24.27 x 1100|
|Day's Range||23.75 - 24.31|
|52 Week Range||22.12 - 47.80|
|Beta (5Y Monthly)||0.60|
|PE Ratio (TTM)||52.83|
|Earnings Date||Jul 18, 2022 - Jul 22, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for NEOG
Neogen's (NEOG) robust segmental performance and notable product launches instill investors' confidence.
Neogen's (NEOG) newest addition to the biosecurity portfolio is anticipated to curb the spread of diseases like COVID-19 and avian influenza.
Neogen® Corporation (NASDAQ: NEOG) announced today that the Natural and Non-Prescriptive Health Products Directorate Branch of Health Canada has granted approval for the distribution of Neogen® Viroxide Super™ in Canada.